Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01776840 |
|---|---|
| Brief Title: | A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma |
| First Submitted : | January 24, 2013 |
| First Submitted that Met QC Criteria : | January 24, 2013 |
| First Posted : | January 28, 2013 (Estimate) |
| Results First Submitted : | June 30, 2022 |
| Results First Submitted that Met QC Criteria : | June 30, 2022 |
| Results First Posted : | July 26, 2022 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 25, 2024 |